70 71
Contour
®
next blood glucose monitoring system
TECHNICAL INFORMATION
Comparison Options: The Contour next system is designed
for use with capillary and venous whole blood. Comparison with a
laboratory method must be done simultaneously with aliquots of the
same sample.
NOTE: Glucose concentrations drop rapidly due to glycolysis
(approximately 5%–7% per hour).
8
References
1. Joslin Diabetes Center. Ketone Testing: What You Need to Know.
Accessed September 25, 2018. https://www.joslin.org/info/ketone_
testing_what_you_need_to_know.html
2. Wickham NWR, et al. Unreliability of capillary blood glucose in
peripheral vascular disease. Practical Diabetes. 1986;3(2):100.
3. Atkin SH, et al. Fingerstick glucose determination in shock. Annals of
Internal Medicine. 1991;114(12):1020-1024.
4. Desachy A, et al. Accuracy of bedside glucometry in critically ill
patients: inuence of clinical characteristics and perfusion index.
Mayo Clinic Proceedings. 2008;83(4):400-405.
5. American Diabetes Association. Standards of medical care in
diabetes—2016. Diabetes Care. 2016;39(supplement 1):S15.
6. US Food and Drug Administration. Use of ngerstick devices
on more than one person poses risk for transmitting bloodborne
pathogens: initial communication. US Department of Health and
Human Services; update 11/29/2010. http://wayback.archive-it.
org/7993/20170111013014/http://www.fda.gov/MedicalDevices/
Safety/AlertsandNotices/ucm224025.htm
7. Centers for Disease Control and Prevention. Infection Prevention
during Blood Glucose Monitoring and Insulin Administration. US
Department of Health and Human Services; update June 8, 2017.
http://www.cdc.gov/injectionsafety/blood-glucose-monitoring.html
8. Burtis CA, Ashwood ER, editors. Tietz Fundamentals of Clinical
Chemistry. 5th edition. Philadelphia, PA: WB Saunders Co; 2001;444.
To Next Page
Loading...
Need help?
General
